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Genomic DNA copy-number alterations (CNAs) are associated with complex diseases, including cancer: CNAs are
indeed related to tumoral grade, metastasis, and patient survival. CNAs discovered from array-based comparative
genomic hybridization (aCGH) data have been instrumental in identifying disease-related genes and potential
therapeutic targets. To be immediately useful in both clinical and basic research scenarios, aCGH data analysis requires
accurate methods that do not impose unrealistic biological assumptions and that provide direct answers to the key
question, ‘‘What is the probability that this gene/region has CNAs?’’ Current approaches fail, however, to meet these
requirements. Here, we introduce reversible jump aCGH (RJaCGH), a new method for identifying CNAs from aCGH; we
use a nonhomogeneous hidden Markov model fitted via reversible jump Markov chain Monte Carlo; and we
incorporate model uncertainty through Bayesian model averaging. RJaCGH provides an estimate of the probability
that a gene/region has CNAs while incorporating interprobe distance and the capability to analyze data on a
chromosome or genome-wide basis. RJaCGH outperforms alternative methods, and the performance difference is even
larger with noisy data and highly variable interprobe distance, both commonly found features in aCGH data.
Furthermore, our probabilistic method allows us to identify minimal common regions of CNAs among samples and can
be extended to incorporate expression data. In summary, we provide a rigorous statistical framework for locating
genes and chromosomal regions with CNAs with potential applications to cancer and other complex human diseases.
Citation: Rueda OM, Dı ´az-Uriarte R (2007) Flexible and accurate detection of genomic copy-number changes from aCGH. PLoS Comput Biol 3(6): e122. doi:10.1371/journal.
pcbi.0030122
Introduction
Alterations in the number of copies (gains, losses) of
genomic DNA have been associated with several hereditary
anomalies and are involved in human cancers [1–7]. For
example, ampliﬁcation of some genes, especially oncogenes,
is one well-known mechanism for tumor activation [8,9], and
it is involved in the deregulation of cellular control [10,11].
Copy-number alterations (CNAs) have been associated with
tumoral grade, metastasis development, and patient survival
[1–7], and studies about copy-number changes have been
instrumental for identifying relevant genes for cancer
development and patient classiﬁcation [1,2,12].
A widely used technique to identify copy-number changes
in genomic DNA is array-based comparative genomic hybrid-
ization (aCGH). Two DNA samples (e.g., problem and control)
are differentially labeled (often with ﬂuorescent dyes) and
competitively hybridized to chromosomal DNA targets. After
hybridization, emission from each of the two ﬂuorescent dyes
is measured, and the signal intensity ratios are indicative of
t h er e l a t i v ec o p yn u m b e ro ft h et w os a m p l e s[ 1 , 2 , 1 3 ] .
Therefore, a key step in any study of the relationship between
altered copy numbers and disease is using the ﬂuorescence
ratio data to identify genes and contiguous chromosomal
regions with altered copy numbers.
The main biomedical problem, both for the study of the
CNAs per se and for downstream analysis (e.g., relationship
with gene expression changes or patient classiﬁcation), is the
accurate identiﬁcation of the genes/chromosomal regions
that have an altered copy number. Satisfactorily dealing with
this problem requires a method that (1) provides direct
answers that can be used in different settings (e.g., clinical
versus basic research), (2) reﬂects the underlying biology and
accounts for key features of the technological platform, and
(3) can accommodate the different levels of analysis (types of
questions) addressed with these data.
First, estimates of the probabilities of alteration (instead of
p-values or smoothed means) are the most direct and usable
answer to this problem [14,15]. Probabilities can be used in
contexts that cover basic research to clinical applications [1,2]
so that, for instance, a clinician might require high certainty
of alteration of a speciﬁc gene before more invasive
procedures, whereas a basic researcher can consider for
further study genes that show only a moderate probability of
alteration (e.g., probability .0.5). Finally, appropriately used,
probabilities of alteration can account for uncertainty in
model building [16,17].
Second, the analysis should incorporate distance between
probes [2,15,18–21]: widely used aCGH platforms such as
those based on cDNA microarrays, oligonucleotide arrays,
and representational oligeonucleotide microarray analysis
(ROMA) lead to variable coverage across chromosomes, with
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probes that are very close to each other, whereas in other
regions probes are very far apart). As copy-number changes
involve chromosome segments, contiguous loci will have the
same copy number, unless there is an abrupt change to
another copy number [1,22]: the farther apart two loci are,
the more likely it is that a copy-number event will have taken
place in between them. Thus, in densely covered regions, the
copy number of a probe is a good predictor of the copy
number of the neighboring probes. In contrast, in poorly
covered regions, contiguous probes or loci might be many
thousands of kilobases apart, making it more likely that at
least one copy-number change has taken place, and con-
sequently, a probe provides less information about the likely
state of its neighboring probes. Therefore, unless we use a
platform where all probes are equally spaced, we need to use
the distance between probes (and not just the order) so that
the information that consecutive probes provide is ad-
equately accounted for.
Third, depending on the focus of the study, the analysis
should be conducted either chromosome by chromosome, or
genome-wide [14–16]. Analyses at the chromosome level are
appropriate to detect alterations in copy numbers of loci
relative to the rest of the loci in that same chromosome,
regardless of that chromosome’s ploidy (a trivial example
would be detection of copy-number changes in loci of the
human Y chromosome in an otherwise diploid genome). On
the other hand, detection of copy-number changes that affect
most of a chromosome often require genome-wide analysis
(in chromosome-wide analysis, as the mean or median
chromosome level is used as the reference, detection of such
changes is virtually impossible). Moreover, the use of genome-
wide analysis can offer statistical advantages (e.g., reduced
variance of estimation). As both types of analysis offer
complementary information because they focus on different
biological phenomena (chromosomal gains/losses versus gains
of loci within chromosomes), a suitable method should allow
these two approaches.
Previous Approaches
Available methods for the analysis of aCGH fail some or
most of these requirements. Smoothing techniques [21,23–28]
do not use interprobe distance, nor do they provide posterior
estimates of the likely state of each probe/clone, and data
from each chromosome are analyzed independently of each
other. Hidden Markov models (HMMs) and related techni-
ques offer a ﬂexible modeling framework, and can provide
probabilities of alteration [14–16]. Some HMM-based meth-
ods [16,19], however, do not incorporate the distance between
probes, assuming instead that interprobe distance is constant.
In addition, most of them do not deal satisfactorily with the
unknown number of hidden states (the true number of states
of copy number). Some methods ﬁx in advance the number of
hidden states to three [14,15] or four [16]: prespeciﬁcation of
the number of states has the consequence of jumbling all
changes involving multiple gains into a single state with a
common mean, which is biologically questionable [22],
especially as the resolution of the technology improves.
Moreover, the identiﬁcation of important genes for disease
sometimes requires examining the amplitude of CNAs and
not just their presence and location [1]; collapsing states into
three or four, however, precludes examining in ﬁne enough
detail the amplitude of CNAs. A better approach would
provide posterior probabilities of the number of states; using
such a procedure over many different experiments will tell us
whether three- or four-state models are a reasonable
simpliﬁcation. Of those methods that do not assume a ﬁxed
number of hidden states [18,19,22], one of them [22] cannot
be used for questions about the number of hidden states, or
for breaking the data into more categories than gained/lost/
no change, which are increasingly important questions with
higher-resolution techniques and are needed for distinguish-
ing regions of moderate copy gains from regions of large copy
gains; see also above for relationship between amplitude of
CNAs and presence of disease genes. The remaining two
[18,19] ﬁt HMMs for a range of number of states and then use
Akaike information criterion (AIC)–based model selection,
but AIC-based selection with HMMs has not been theoret-
ically justiﬁed [29] and does not provide a probability of the
likely number of states; moreover, selecting a single model
leads to underestimation of the true variability in the data.
These two methods, in addition, use a ﬁnal clustering step of
hidden states that introduces several ad hoc decisions.
Statistical Model: Overview
We have developed a method, reversible jump aCGH
(RJaCGH), that fulﬁlls the three requirements above, and does
not suffer from the limitations discussed for other methods.
Our method is applicable to aCGH from platforms including
ROMA, oligonucleotide aCGH (oaCGH; including Agilent,
NimbleGen, and many noncommercial, in-house oligonucleo-
tide arrays), bacterial artiﬁcial chromosome (BAC), and cDNA
arrays [1,13]. We start our modeling by noting that, for a
given chromosome or genome, the copy numbers of genomic
DNA (e.g., 0, 1, 2 copies, ...)o fdifferent probes or segments
are an unknown ﬁnite number. Thus, probes or segments
could be classiﬁed into several groups with respect to their
(unknown) copy number. In addition, as mentioned above, we
expect that the copy number of a probe will be similar to the
copy number of its closest neighbors, with that expected
similarity decreasing when probes are farther apart. Finally,
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Author Summary
As a consequence of problems during cell division, the number of
copies of a gene in a chromosome can either increase or decrease.
These copy-number alterations (CNAs) can play a crucial role in the
emergence of complex multigenic diseases. For example, in cancer,
amplification of oncogenes can drive tumor activation, and CNAs are
associated with metastasis development and patient survival.
Studies on the relationship between CNAs and disease have been
recently fueled by the widespread use of array-based comparative
genomic hybridization (aCGH), a technique with much finer
resolution than previous experimental approaches. Detection of
CNAs from these data depends on methods of analysis that do not
impose biologically unrealistic assumptions and that provide direct
answers to fundamental research questions. We have developed a
statistical method, using a Bayesian approach, that returns estimates
of the probabilities of CNAs from aCGH data, the most direct and
valuable answer to the key biological question: ‘‘What is the
probability that this gene/region has an altered copy number?’’ The
output of the method can therefore be immediately used in
different settings from clinical to basic research scenarios, and is
applicable over a wide variety of aCGH technologies.
Analysis of aCGH Datafor a given copy number, the aCGH ﬂuorescence ratios
should be centered around a log2 value, with some random
noise. We want to use the observed log-ratios to identify
regions with altered copy number.
The biological features of this model (a ﬁnite number of
unknown or hidden states that are indirectly measured, with
states of close elements likely to be similar, and variable
distances between probes) can be modeled with a non-
homogeneous HMM [29]. To provide a direct estimate of the
probability that a given probe or region has an altered copy
number, we use a Bayesian model computed via Markov chain
Monte Carlo (MCMC). Since we do not know the true number
of hidden states, we ﬁt models with varying numbers of
hidden states and, to allow for transdimensional moves
between models with different numbers of states, we used
reversible jump [30]. After running a large number of MCMC
iterations, we can summarize the posterior probabilities.
First, we obtain posterior probabilities for the number of
states. Conditional on a given number of states, each model
provides posterior distributions of the parameters of interest
(e.g., means, variances, transition matrices). From the latter,
we can obtain posterior probabilities that a probe is gained
or lost. To obtain our ﬁnal estimates, we incorporate the
uncertainty in model selection by using Bayesian model
averaging [17], with estimates weighted by the posterior
probability of each number of states, for the probabilities of
probes being gained or lost. We call the complete statistical
method RJaCGH (from reversible jump–based analysis of
aCGH data).
Results
We applied RJaCGH and the best performing alternative
methods (based on two recent reviews [20,31]) to the 500
simulated datasets of [31] (see also Protocol S1). These are
data ‘‘...simulated to emulate the complexity of real tumor
proﬁles’’ and designed to become ‘‘...a standard for systematic
comparisons of computational segmentation approaches,’’
[31] and are not data simulated under our own model. To
assess the effect of variable interprobe distance, we randomly
deleted data points (see details in Protocol S1) so that each
original simulated dataset gives rise to another four datasets
with (an average of) 10%, 25%, 50%, and 65% of observations
missing. The length of these gaps is modeled by a Poisson
distribution, so larger percentages of missing data corre-
spond to larger variability in interprobe distances.
Results in Figure 1 (see also Figure 1 in Protocol S1) show
the excellent performance of RJaCGH, and how it outper-
forms alternative methods. Moreover, Figure 2 (see also
Figures 2 and 3 in Protocol S1) shows that the difference
between RJaCGH and alternative approaches is accentuated
when we consider jointly the effects of noise and variability in
interprobe distance. Analysis using three other performance
statistics (false discovery rate, sensitivity, and speciﬁcity) show
the same overall patterns (see Protocol S1, Figures 2 and 3):
for some speciﬁc statistics, RJaCGH can be second (but very
close) to another approach; this other approach, however,
performs poorly with respect to the remaining statistics.
This paper focuses on the statistical performance of the
methods compared. In terms of speed, nevertheless, our
approach is clearly the slowest one. We are currently working
on improving the speed of the execution both by using more
efﬁcient algorithms and by using parallel computing.
Similar results are obtained when applying these methods
to a real dataset of nine cell lines [32], and when comparing
the predicted ploidy with the known ploidy (see Protocol S1,
Figure 4). Overall, therefore, there is strong evidence that
RJaCGH is the best performing of the existing methods.
Discussion
The excellent performance of RJaCGH is a result of the
statistical method used, which is essentially a careful and
rigorous development from ﬁrst principles. We set out to
obtain a method that allows us to seamlessly incorporate
interprobe distances (to allow usage over varied technological
platforms), that makes no untenable assumptions about the
true number of copy levels (since this is likely to vary between
datasets), that permits analysis at the chromosome and the
genome level, and, ﬁnally, that returns posterior probabilities
of alteration, because these posterior probabilities constitute
the direct answer to the basic biomedical question (‘‘Is this
gene likely to have an altered copy number?’’).
Based simply on our usage of interprobe distance, we
should expect RJaCGH to perform better than all alternative
approaches, with the possible exception of BioHMM [18], as
interprobe distance variability increases. Moreover, RJaCGH
adapts to variable noise in the data, without the need for ﬁne-
tuning of parameters (all results reported are obtained from
the default settings of RJaCGH). As noted above, the relative
advantage of RJaCGH increases as the interprobe variability
increases and the noise in the data increases, which shows
that our theoretical developments have practical consequen-
ces and emphasizes the importance of both accounting for
interprobe distance and appropriately modeling variance in
the data.
In addition, we use Bayesian model averaging, which has
been repeatedly shown [33] not only to account for
uncertainty in model selection but also to lead to point
estimators and predictions that minimize mean square error.
On its own, our usage of Bayesian model averaging could be
largely responsible for the better performance of RJaCGH
over all other methods, even in the absence of interprobe
distance variability and when there is low noise in the data
(left of Figure 1, and left of bottom-row panels in Figure 2). In
addition, reversible jump allows us to consider a variety of
models (regarding number of states), and its birth and split
moves are also beneﬁcial for a more thorough exploration of
the posterior probability (within a model with a given
number of states) when the density is multimodal. Finally,
our method, in contrast to other approaches (e.g., DNAcopy),
can identify single-clone aberrations, which might be key for
large-scale genomic deregulation if the single-clone aberra-
tions affect certain speciﬁc genes or promoters; for example,
the inability to detect single-gene alterations is shown to have
an effect in a study of pancreatic adenocarcinoma [5], where
the loss of the SMAD4 tumor suppressor is undetected.
In addition to features that can be compared with other
methods, RJaCGH has two unique features that set it apart
from most alternative approaches. First, the user can analyze
data at either the genome or the chromosome level, thus
addressing different types of questions. Some approaches
(e.g., BioHMM, HMM, GLAD, DNAcopy) allow us to perform
PLoS Computational Biology | www.ploscompbiol.org June 2007 | Volume 3 | Issue 6 | e122 1117
Analysis of aCGH Datagenome-wide inferences, but they use essentially an ad hoc
postprocessing of results of analysis that is conducted at the
chromosome level. Finally, one of the main features of
RJaCGH, its returning of posterior probabilities of CNAs,
simply cannot be compared with most alternative methods as
they do not provide this type of output. What most
alternative approaches return are smoothed means, p-values,
or a classiﬁcation into states without any assessment of the
uncertainty of this assignment to states. But a probability of
alteration (which RJaCGH returns) is much easier to interpret
and to use (with possibly different thresholds depending on
the type of research question), and is often the direct answer
to the basic biomedical question. The few alternative
approaches that return probabilities of alteration [14–16]
all make the untenable assumption that the true number of
biological states of alteration is three [14,15] or four [16].
Directly returning probabilities of alterations has profound
consequences, both for current practices and for future
developments. As argued above, these probabilities are the
direct answer to the question ‘‘Does this gene have an altered
copy number?’’; p-values or smoothed means are not a direct
(and often not even an indirect) answer to that question. In
addition, the improvement in the resolution of aCGH
techniques [2,13] is increasingly allowing for multiple assayed
spots per gene. Probabilities of alteration for each spot can be
combined to ﬁnd the gene-level probability of alteration, a
distinct advantage over smoothed means or p-values.
For currently active research areas, the availability of
rigorously obtained probabilities of alterations has far-
reaching consequences, both in terms of the biological
phenomena that can be exposed and as an avenue of further
research. First, the availability of probabilities of alteration
should improve the identiﬁcation of regions with consistent
alterations across samples [34,35] in a statistically rigorous
way (including, if needed, control of false discovery rate), and
the detection of subgroups of samples according to recur-
rence patterns [4,35,36]. Critical disease genes are often
located in CNAs that are recurrent across individuals and
that have at least some high-amplitude changes [1,35,37], and
analysis of aCGH data has allowed us to identify subgroups,
within established diseases, that could have therapeutic
relevance (e.g., in glioblastoma [4]). Available methods use
the assignment of each gene to one state (equivalent to
assuming that there is complete certainty in this assignment);
however, we would not want to give the same weight, when
looking for minimal common regions, to a gene with a
probability of being gained of 51% and to a gene with a
probability of being gained of 90%, since this practice will
lead to a coarser deﬁnition of boundaries and can even
preclude the detection of some minimal regions altogether.
The inherent limitations of methods that use a simple
categorization into gain/loss/no change with an assumed
100% certainty have already been recognized by some of
the developers of such methods [35]. Moreover, incorpora-
tion of amplitude of change, which might be a crucial feature
of minimal common regions that harbor critical disease genes
[1,5,35,37], is not feasible with some methods [34], but should
be straightforward by combining posterior probabilities and
posterior means of each state, as returned from RJaCGH.
Second, posterior probabilities of being in a speciﬁc state,
together with the estimated posterior mean of each state, can
be used as the basis for a statistically rigorous and biologically
sound approach for identifying breakpoints. At present, the
identiﬁcation of breakpoints depends completely on the
resolution of the method, and does not allow us to combine
the probability of membership in different states with the
biological relevance of an estimated mean difference; how-
ever, the precise deﬁnition of boundaries and ampliﬁcation
Figure 1. Effects of Variability in Interprobe Distance (Percentage of Probes Missing) on Correct Classification
Shown are the mean and 95% confidence interval around the mean of the correct classification error rate. Each mean and confidence interval is
computed from 500 datasets [31]; see text and Protocol S1 for generation of interprobe distance variability. Alternative methods compared are ACE,
developed by [27]; BioHMM, a nonhomogeneous HMM by [18]; DNAcopy with mergeLevels, with the original method developed by [24] (and use of
mergeLevels following [31]); HMM, a homogeneous HMM developed by [19]; CGHseg, a random Gaussian process with abrupt changes in the mean by
[28]; and GLAD, which uses a nonparametric likelihood method with adaptive weights for breakpoint detection, by [23].
doi:10.1371/journal.pcbi.0030122.g001
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Analysis of aCGH Datamaxima are important not only for the study of genomic copy
numbers, but also for understanding the relationship
between aCGH and expression data [38].
Third, the model of RJaCGH can be extended to provide
rigorous downstream analysis of aCGH, including patient
classiﬁcation [1,31] and the integration of gene expression
and proteomic data [12,31]. CNA data analysis, compared
with mRNA expression data, can be performed on formalin-
ﬁxed parafﬁn-embedded material, and CNAs deﬁne key
events that drive tumorigenesis, and thus are probably more
valuable as prognostic markers and as predictors of treatment
response [39,40]. Improved resolution of CNA data analysis,
however, can be crucial in obtaining very valuable classiﬁers,
as evidenced from the ‘‘almost success’’ of some studies
attempting to differentiate BRCA2 from BRCA1, BRCAX, and
sporadic cases in breast tumors (see discussion in [40]); the
ﬁner resolution provided by probabilities and posterior mean
estimates might be pivotal here. Incorporating expression
and proteomic data, on the other hand, is the basis for the
identiﬁcation of copy-number changes that are signiﬁcant in
the development of disease [1,41,42]. Since changes in copy
number are not always reﬂected in changes in expression
[1,5], analytical methods that provide ﬁner resolution are
crucial. Moreover, within a probabilistic framework it is
possible to systematically and rigorously address questions of
how CNAs in a given chromosome affect expression changes
in genes located in other chromosomes, an increasingly
important research question [43]. Finally, the posterior
probabilities and means returned from aCGH can be
considered as denoised [44,45] signals from the log2 aCGH
ratios that reﬂect underlying copy number variation; as such,
these are highly relevant to the recent studies on the
relationship between copy-number variation and complex
phenotypes [46,47], which emphasize the importance of copy-
number variation in genetic diversity and disease in humans.
Materials and Methods
Model. We use a nonhomogeneous HMM with Gaussian emissions.
We can either ﬁt one model to all the chromosomes of an array, or we
can ﬁt a different model for each chromosome of an array. Let n be
the number of probes, and k the number of different copy numbers
in the collection of probes. Let Si be the true state (copy number) of
the probe i: Si¼f1, ...,k gi ¼1,...,n. Let Yi be the relative copy number of
the probe i, that is the log ratio of ﬂuorescence intensities between
tumor and control samples. Let di be the distance in bases between
probe i and probe i þ 1. How distance is measured depends on the
platform: distance can be the distance from the end of the spot to the
start of the next, if the length of the spots is proportional to the
length of the probe (so we have the same information for every
probe), or the distance between the midpoint of the spots, if the
length of the spots is not proportional to the length of the probe. We
Figure 2. Joint Effects of Variability in Interprobe Distance and Noise on Correct Classification
The same data are shown as those in Figure 1. The noise (standard deviation) of each sample is split into ten non-overlapping ranges, and each panel
shows the mean correct classification success versus the proportion of missing probes (i.e., increasing levels of variance in interprobe distance). Each
mean is based on approximately 50 samples. See Figure 1 for method references.
doi:10.1371/journal.pcbi.0030122.g002
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Analysis of aCGH Datanormalize these distances between 0 and 1 to increase numerical
stability (with probes in adjacent bases with a scaled distance of 0).
We assume that fSig follows a nonhomogeneous ﬁrst-order Markov
process, as: P(Si¼si j Si 1¼si 1, Xi 1¼xi 1)¼Qsi 1;Si 1;Xi 1 Biologically, we
expect that QSi 1¼r;Si¼r;Xi 1,the probability of staying in the same
hidden state, is a decreasing function of Xi 1, so the dependence of
the state of a probe onto the next one is lower the farther the probes
are. We also expect that when the distance between two probes is
maximal, the state of a probe should be independent from the state of
its predecessor. Thus, we model the transition probabilities as:
Qi;j;x ¼
expf bi;j þ bi;jxg
X k
p¼1
expf bi;p þ bi;pxg
ð1Þ
where b has the form:
b ¼
0 b1;2 ... b1;k
b2;1 0 ... b2;k
. .
. . .
. ..
. . .
.
bk;1 bk;2 ... 0
0
B B B @
1
C C C A
ð2Þ
with all bij   0 8 i, j. Finally, conditioned on fSig, fYig follows a
Gaussian process: ðYijSi ¼ siÞ : Nðlsi;r2
siÞ
Similar approaches have been used before with nonhomogeneous
HMM [48,49]. In our case, the transition matrix should fulﬁll the
following biologically based properties: (1) the probability of
remaining in the same hidden state should be a decreasing function
of the distance between a probe and the previous probe; and (2) when
the distance between two probes is maximal, the state of a probe
should not be affected by the state of the previous probe. With the
above parameterization, and since the diagonal of b is zero (which
is also needed for the parameters to be uniquely deﬁned),
the probability of remaining in the same state i is
1=
Pk
p¼1 expf bi;p þ bi;pxg, a decreasing function of distance (x).
Moreover, as distances are scaled between 0 and 1, when the distance
between two probes is 1, the probability of staying in the same state is
1/k , where k is the number of states; therefore, when the distance is
maximal, the state of a probe does not depend on the state of the
previous probe. (The value of this ‘‘maximal distance’’ beyond which
two probes are considered independent is a parameter to the model,
and can be adjusted taking into account the speciﬁc array character-
istics).
For computational reasons and modeling ﬂexibility, we opted for
Bayesian methods using MCMC. To ﬁt models with varying number of
hidden states, we used reversible jump. Suppose that we have a
collection of K HMM models, and each of them has a number of k
hidden states, from k¼f1 ,... ,K g. Let h(k) be the HMM associated to k,
that is, h(k) ¼fl(k), r
2(k), b(k)g. The prior distributions for the model
are the usual ones in mixture problems [50]: p(k) is the prior for the
number of hidden states with p(k) ; U(1,k), p(h(k)j k) is the prior of the
HMM conditioned to k, the number of hidden states with u(k) ;
N(a,.
2), where a and . are the median and range of Yi; r
2(k) ; IG(ka,
g), where ka is 2 and g is .
2(Yi) / 50; bk) ; C(1, 1). The likelihood of the
model, L(y; k, h(k)) can be computed by forward ﬁltering [29], so the
joint distribution is p(k)p(h(k)jk) L(y; k, h(k)).
Estimation and ﬁtting. We can draw samples from the posterior
distribution through a reversible jump MCMC (RJMCMC) algorithm
[30]. In RJMCMC, we explore the posterior distribution of possible
models, jumping not only within a model but also between models
with a different number of parameters. To match the difference
between degrees of freedom, some random numbers u with density
P(u) are generated, so if we are in state x, the new one is proposed in a
deterministic way x9(x,u). The reverse move is the inverse of that
function: x(x9,u9). This way, the usual Metropolis-Hastings acceptance
probability can be computed [50]:
minf1;
LðyjxÞpðx9Þpðu9jx9Þ
LðyjxÞpðxÞpðujxÞ
jJjg ð3Þ
where L(y j x) is the likelihood, p(x) are the priors, p(u j x) are the
densities of the candidates, and J ¼j @x9
@ðx;uÞj the determinant of the
Jacobian of the change of variable. We combine several Metropolis
steps in a sweep [29,51].
(1) Update HMM of a model using a series of Metropolis-Hastings
moves. (We do not use Gibbs Sampler to avoid the hidden state
sequence from becoming part of the state space of the sampler, so
dimensionality is reduced and reaching convergence is easier).
(2) Update model (birth/death). When we have r states, a birth/
death move is chosen with probabilities pbirth(r) and pdeath(r) (these are
1/2 except in the cases when no movement of that type can be made,
[e.g., a death move when there is only one state]). If a birth move is
selected, a new state is created from the prior distributions and
accepted with probability
minf1;pg; where
p ¼
Lðy;r þ 1;hðr þ 1ÞÞpðk ¼ r þ 1Þpdeathðr þ 1Þ
Lðy;r;hðrÞÞpðk ¼ rÞpbirthðrÞ
3jJbirthj
and Jbirth ¼ 1
ð4Þ
If a death move is chosen, a random state is deleted with a probability
inverse to Equation 4.
(3) Update model (split/combine). A split/combine move is
attempted with probabilities psplit(r) and pcombine(r) (again, 1/2 except
when a move cannot be made). If a split move is selected, an existing
state i0 is split into two, i1, i2:
li1 ¼ li0   el;li2 ¼ li0 þ el;el ;Nð0;slÞð 5Þ
r2
i1 ¼ r2
i0er; r2
i2 ¼ r2
i0ð1   erÞ; er ;bð2;2Þ: ð6Þ
Split column
i0 ;bi;i1 ¼ bi;i0eb;bi;i2 ¼ bi;i0=eb;
eb ;LNð0;sbÞ for i 6¼ i0 ð7Þ
Split row
i0 ;bi1;j ¼ bi0;jUj;bi2;j ¼ bi0;jð1   UjÞ;
where Uj ;bð2;2Þ for j 6¼ i0
bi1;i2 ;Cð1;1Þ: ð8Þ
This move is accepted with probability
minf1;pg; where
p ¼
Lðy;r þ 1;hðr þ 1ÞÞðr þ 1Þ
Lðy;r;hðrÞÞ
3
pðk ¼ r þ 1ÞPðhðr þ 1ÞÞPcombineðr þ 1Þr
pðk ¼ rÞPðhðrÞÞPsplitðrÞðr þ 1Þ
3
1
2PðelÞPðerÞPPðerÞPPðUjÞ
jJsplitj
and jJsplitj¼j 2rr2
i0 P
j6¼i0
bi0;j P
i6¼i0
bi;i0
eb
jð 9Þ
The split move must follow the adjacency condition [50]: the resulting
states must be closer between them than to any other existing ones. If
a combine step is selected, the symmetric move is performed, and the
inverse probability of acceptance is computed.
The combination of birth and split moves makes it possible not
only to visit models with a different number of parameters, but also
to explore more thoroughly the posterior probability in the case of a
parameter with a multimodal density.
These moves are common ones [29,51], but we have changed
several aspects of their design to improve the probability of
acceptance, which is the most difﬁcult step in reversible jump
[29,30,51]. We constrain the variance of every state so that it cannot
be greater than the variance of the entire data. Also, we have added
the adjacency condition mentioned before, and used centering
proposals [52]. To prevent label-switching of states, we have ordered
the states according to means after every iteration of the sweep [50].
Inference. We run the former algorithm a large number of times
(e.g., 50,000) and, after discarding the ﬁrst iterations as burn-in, we
keep the last (e.g., 10,000) samples as observations from the joint
distribution so that we can make inferences from it. For every model
that has been visited, we obtain the posterior probabilities of the
mean copy number of every state, the variance of the copy number of
every state, and the function of transitions between hidden states. By
counting the number of times that each model has been visited, we
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Analysis of aCGH Dataobtain an estimate of the posterior probability of each model (i.e., we
avoid using Bayesian information criterion [BIC] or AIC). Then,
applying the Viterbi algorithm [29] to every sample obtained from
the MCMC, and, as this sample is a function of the HMM, we can
obtain its posterior probability, something that usual Viterbi cannot.
From the Viterbi paths for all the samples, we can then compute the
posterior probability that a probe belongs to every state or the
probability that a sequence of probes is in a given state.
When obtaining posterior probabilities of copy-number change,
we use Bayesian model averaging [17] over all models visited. Let Si be
the lost, gained, no-change status of probe i, K the set of the models
considered (in our case, that would be HMMs with 1, . . ., K number of
states), Mk the model with k number of states, and Si j Mk the state of
probe i according to model k. We compute the unconditional (with
respect to model selection) probability for the probe i as:
pðSi ¼ sijyÞ¼
X
k2K
pðMkjyÞpðSi ¼ sijMk;yÞ: ð10Þ
Checking convergence and inﬂuence of priors. As in any MCMC
approach, it is crucial to assess convergence of the sampler. We follow
common practice [53] of running several chains in parallel. The
convergence of the sampler depends strongly on the distribution of
the candidates in Metropolis-Hastings. That is, for every iteration, a
new value for the parameters is proposed from a distribution
centered in their current values. The standard deviation of that
distribution must be chosen in a way that samples explore all the
parameter space. These standard deviations are not parameters of the
model in the sense that different values give different ﬁts, but values
that can speed up convergence of the algorithm. The convergence of
the posterior probability of the number of hidden states is reached
when a large enough number of transdimensional moves is made.
This number need not to be large if the likelihood is substantially
higher in a particular model and data size is big enough. The birth
and death moves only depend on the priors, but the split and
combine moves depend also on their own design and the values of sl
and sb (see Equation 5 and Equation 7). The priors chosen have been
extensively tested in mixture models [50]. In addition, the priors and
rest of the parameters have very little effect: even small CGH arrays
contain thousands of points, so that the likelihood from the data
dominates any prior. With the 2,500 simulated datasets analyzed, we
have only needed to specify the number of burn-in—50,000—and to-
keep samples—10,000, and the number of chains—four, and in only
nine cases was there evidence of nonconvergence, which was solved
by rerunning the samplers.
Implementation and analysis. We have implemented RJaCGH
using C (for the sweep algorithm) and R [54], and all analysis and
comparisons have been done in R. The code that implements
RJaCGH is freely available from the usual Comprehensive R Archive
Network (CRAN) repositories as package RJaCGH (http://cran.
r-project.org/src/contrib/Descriptions/RJaCGH.html) or from the re-
pository at Launchpad (https://launchpad.net/rjacgh). All data and
code used for this paper are also publicly and freely available (see
details in Protocol S1).
Supporting Information
Protocol S1. Supplementary Material
Found at doi:10.1371/journal.pcbi.0030122.sd001 (551 KB PDF).
Acknowledgments
C. La ´zaro-Perea, A. Alibe ´s, L. Hsu, D. Grove, two anonymous
reviewers, and J. F. Poyatos especially provided discussion and
comments on the paper. RDU is partially supported by the Ramo ´n
y Cajal programme of the Spanish Ministry of Education and Science
(MEC).
Author contributions. OMR developed the statistical model, did
most of the programming, and conducted analysis. RDU conceived
the model, participated in model development and programming,
and conducted simulations. Both authors wrote the paper.
Funding. Funding was provided by Fundacio ´n de Investigacio ´n
Me ´dica Mutua Madrilen ˜a and Project TIC2003–09331-C02–02 of the
Spanish Ministry of Education and Science (MEC).
Competing interests. The authors have declared that no competing
interests exist.
References
1. Pinkel D, Albertson DG (2005) Array comparative genomic hybridization
and its applications in cancer. Nat Genet 37 (Supplement): S11–S17.
2. Lockwood WW, Chari R, Chi B, Lam WLa (2006) Recent advances in array
comparative genomic hybridization technologies and their applications in
human genetics. Eur J Hum Genet 14: 139–148.
3. Urban AE, Korbel JO, Selzer R, Richmond T, Hacker A, et al. (2006) High-
resolution mapping of DNA copy alterations in human chromosome 22
using high-density tiling oligonucleotide arrays. Proc Natl Acad Sci U S A
103: 4534–4539.
4. Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, et al. (2005) Array
comparative genomic hybridization identiﬁes genetic subgroups in grade 4
human astrocytoma. Clin Cancer Res 11: 2907–2918.
5. Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, et al. (2004) High-
resolution characterization of the pancreatic adenocarcinoma genome.
Proc Natl Acad Sci U S A 101: 9067–9072.
6. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. (2004) Large-scale
copy number polymorphism in the human genome. Science 305: 525–528.
7. Forozan F, Mahlama ¨ki EH, Monni O, Chen Y, Veldman R, et al. (2000)
Comparative genomic hybridization analysis of 38 breast cancer cell lines:
A basis for interpreting complementary DNA microarray data. Cancer Res
60: 4519–4525.
8. Heiskanen MA, Bittner ML, Chen Y, Khan J, Adler KE, et al. (2000)
Detection of gene ampliﬁcation by genomic hybridization to cDNA
microarrays. Cancer Res 60: 799–802.
9. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, et
al. (2004) Genomic DNA-chip hybridization reveals a higher incidence of
genomic ampliﬁcations in pancreatic cancer than conventional compara-
tive genomic hybridization and leads to the identiﬁcation of novel
candidate genes. Cancer Res 64: 4428–4433.
10. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, et al. (2003)
Array-based comparative genomic hybridization for genome-wide screen-
ing of DNA copy number in bladder tumors. Cancer Res 63: 2872–2880.
11. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they
control. Nat Med 10: 789–799.
12. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray
analysis reveals a major direct role of DNA copy number alteration in the
transcriptional program of human breast tumors. Proc Natl Acad Sci U S A
99: 12963–12968.
13. Ylstra B, van den Ijssel P, Carvalho B, Brakenhoff RH, Meijer GA (2006)
BAC to the future! or oligonucleotides: A perspective for micro array
comparative genomic hybridization (array CGH). Nucleic Acids Res 34:
445–450.
14. Engler D, Mohaptra G, Louis D, Betensky R (2006) A pseudolikelihood
approach for simultaneous analysis of array comparative genomic hybrid-
izations. Biostatistics 7: 399–421.
15. Broe ¨t P, Richardson S (2006) Detection of gene copy number changes in
CGH microarrays using a spatially correlated mixture model. Bioinfor-
matics 22: 911–918.
16. Shah SP, Xuan X, Deleeuw RJ, Khojasteh M, Lam WL, et al. (2006)
Integrating copy number polymorphisms into array CGH analysis using a
robust HMM. Bioinformatics 22: e431–e439.
17. Hoeting J, Madigan H, Raftery A, Volinsky C (1999) Bayesian model
averaging: A tutorial. Stat Sci 14: 382–417.
18. Marioni JC, Thorne NP, Tavare ´ S (2006) BioHMM: A heterogeneous hidden
Markov model for segmenting array CGH data. Bioinformatics 22: 1144–
1146.
19. Fridlyand J, Snijders AM, Pinkel D, Albertson DGa (2004) Hidden Markov
models approach to the analysis of array CGH data. J Multivariate Anal 90:
132–153.
20. Lai WRR, Johnson MDD, Kucherlapati R, Park PJJ (2005) Comparative
analysis of algorithms for identifying ampliﬁcations and deletions in array
CGH data. Bioinformatics 21: 3763–3770.
21. Huang T, Wu B, Lizardi P, Zhao H (2005) Detection of DNA copy number
alterations using penalized least squares regression. Bioinformatics 21:
3811–3817.
22. Daruwala RS, Rudra A, Ostrer H, Lucito R, Wigler M, et al. (2004) A
versatile statistical analysis algorithm to detect genome copy number
variation. Proc Natl Acad Sci U S A 101: 16292–16297.
23. Hupe ´ P, Stransky N, Thiery JP, Radvanyi F, Barillot E (2004) Analysis of
array CGH data: From signal ratio to gain and loss of DNA regions.
Bioinformatics 20: 3413–3422.
24. Olshen AB, Venkatraman ES, Lucito R, Wigler M (2004) Circular binary
segmentation for the analysis of array-based DNA copy number data.
Biostatistics 5: 557–572.
25. Price TS, Regan R, Mott R, Hedman A, Honey B, et al. (2005) SW-array: A
dynamic programming solution for the identiﬁcation of copy-number
changes in genomic DNA using array comparative genome hybridization
data. Nucleic Acids Res 33: 3455–3464.
26. Hsu L, Self SG, Grove D, Randolph T, Wang K, et al. (2005) Denoising array-
based comparative genomic hybridization data using wavelets. Biostatistics
6: 211–226.
PLoS Computational Biology | www.ploscompbiol.org June 2007 | Volume 3 | Issue 6 | e122 1121
Analysis of aCGH Data27. Lingjaerde OC, Baumbusch LO, Liestøl K, Glad IK, Borresen-Dale AL
(2005) CGH-explorer: A program for analysis of array-CGH data.
Bioinformatics 21: 821–822.
28. Picard F, Robin S, Lavielle M, Vaisse C, Daudin JJ (2005) A statistical
approach for array CGH data analysis. BMC Bioinformatics 6: 27.
29. Cappe ´ O, Moulines E, Ryden T (2005) Inference in hidden Markov models
(Springer series in statistics). New York: Springer. 652 p.
30. Green P (1995) Reversible jump Markov chain Monte Carlo computation
and Bayesian model determination. Biometrika 82: 711–732.
31. Willenbrock H, Fridlyand J (2005) A comparison study: Applying
segmentation to array CGH data for downstream analyses. Bioinformatics
21: 4084–4091.
32. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, et al. (2001)
Assembly of microarrays for genome-wide measurement of DNA copy
number. Nat Genet 29: 263–264.
33. Raftery AE, Zheng Y (2003) Discussion: Performance of bayesian model
averaging. J Am Statist Assoc 98: 931–938.
34. Rouveirol C, Stransky N, Hupe ´ P, La Rosa P, Viara E, et al. (2006)
Computation of recurrent minimal genomic alterations from array-CGH
data. Bioinformatics 22: 2066–2073.
35. Diskin SJ, Eck T, Greshock J, Mosse YPP, Naylor T, et al. (2006) STAC: A
method for testing the signiﬁcance of DNA copy number aberrations
across multiple array-CGH experiments. Genome Res 16: 1149–1158.
36. Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, et al. (2005) Array
comparative genomic hybridization identiﬁes genetic subgroups in grade 4
human astrocytoma. Clin Cancer Res 11: 2907–2918.
37. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, et al. (2005) High-
resolution genomic proﬁles of human lung cancer. Proc Natl Acad Sci U S
A 102: 9625–9630.
38. Albertson DG, Pinkel D (2003) Genomic microarrays in human genetic
disease and cancer. Hum Mol Genet 12: R145–R152.
39. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, et al.
(2006) Distinct patterns of DNA copy number alteration are associated with
different clinicopathological features and gene-expression subtypes of
breast cancer. Genes Chromosomes Cancer 45: 1033–1040.
40. van Beers EH, Nederlof PM (2006) Array-CGH and breast cancer. Breast
Cancer Res 8: 210.
41. Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, et al. (2006)
Combined cDNA array comparative genomic hybridization and serial
analysis of gene expression analysis of breast tumor progression. Cancer
Res 66: 4065–4078.
42. Habermann JKK, Paulsen U, Roblick UJJ, Upender MBB, McShane LMM, et
al. (2007) Stage-speciﬁc alterations of the genome, transcriptome, and
proteome during colorectal carcinogenesis. Genes Chromosomes Cancer
46: 10–26.
43. Bussey KJ, Chin K, Lababidi S, Reimers M, Reinhold WC, et al. (2006)
Integrating data on DNA copy number with gene expression levels and
drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther 5: 853–867.
44. Parmigiani G, Garrett E, Anbazhaghan R, Gabrielson E (2002) A statistical
framework for expression-based molecular classiﬁcation in cancer. J R Stat
Soc Ser B Stat Methodol 64: 717–736.
45. Garrett E, Parmigiani G (2003) POE: Statistical methods for qualitative
analysis of gene expression. In: Parmigi ani G, Garrett ES, Irizarry RA,
Zeger SL, editors. The analysis of gene expression data: Methods and
software. New York: Springer. pp. 362–387.
46. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. (2006) Global
variation in copy number in the human genome. Nature 444: 444–454.
47. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. (2007)
Relative impact of nucleotide and copy number variation on gene
expression phenotypes. Science 315: 848–853.
48. Kirshner S (2005) Modeling of multivariate time series using hidden
Markov models [dissertation]. Irvine (California): University of California
Irvine. Available: http://www.datalab.uci.edu/papers/kirshner_thesis.pdf.
Accessed 22 May 2007.
49. Hughes PJ, Guttorp P, Charles PS (1999) A nonhomogeneous hidden
Markov model for precipitation. Northwest Research Center for Statistics
and the Environment. Available: http://www.nrcse.washington.edu/pdf/
trs04_hgc.pdf. Accessed 22 May 2007.
50. Richardson S, Green PJ (1997) On Bayesian analysis of mixtures with an
unknown number of components. J R Stat Soc Ser B Stat Methodol 59: 731–
792.
51. Robert C, Ryden T, Titterington D (2000) Bayesian inference in hidden
Markov models through reversible jump Markov chain Monte Carlo. J R
Stat Soc Ser B Stat Methodol 62: 57–75.
52. Brooks SP, Giudici P, Roberts GO (2003) Efﬁcient construction of
reversible jump Markov chain Monte Carlo proposal distributions. J R
Stat Soc Ser B Stat Methodol 65: 3–39.
53. Brooks S, Gelman A (1998) General methods for monitoring convergence
of iterative simulations. J Comput Graph Statist 7: 434–455.
54. R Development Core Team (2006) R: A language and environment for
statistical computing. R Foundation for Statistical Computing. Available:
http://www.R-project.org. Accessed 22 May 2007.
PLoS Computational Biology | www.ploscompbiol.org June 2007 | Volume 3 | Issue 6 | e122 1122
Analysis of aCGH Data